These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 23377519)
21. Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A. Schlessinger J; Kenkel J; Werschler P Aesthet Surg J; 2011 Jul; 31(5):529-39. PubMed ID: 21719866 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718 [TBL] [Abstract][Full Text] [Related]
25. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation. Cook-Bolden FE; Hamilton SF Cutis; 2008 Apr; 81(4):365-71. PubMed ID: 18491487 [TBL] [Abstract][Full Text] [Related]
26. A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia. Wang J; Fabi S; Robinson D; Bajaj S; Geronemus R; Bell M; Widgerow A J Drugs Dermatol; 2023 Apr; 22(4):333-338. PubMed ID: 37026875 [TBL] [Abstract][Full Text] [Related]
27. Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream. Draelos ZD Dermatol Surg; 2005 Jul; 31(7 Pt 2):799-804. PubMed ID: 16029670 [TBL] [Abstract][Full Text] [Related]
28. An evaluation of the benefits of a topical treatment in the improvement of photodamaged hands with age spots, freckles, and/or discolorations. Gold MH; Gallagher C J Drugs Dermatol; 2013 Dec; 12(12):1468-72. PubMed ID: 24301250 [TBL] [Abstract][Full Text] [Related]
29. Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study. Lowe N; Horwitz S; Tanghetti E; Draelos Z; Menter A J Cosmet Laser Ther; 2006 Sep; 8(3):121-7. PubMed ID: 16971360 [TBL] [Abstract][Full Text] [Related]
30. A hydroquinone formulation with increased stability and decreased potential for irritation. Smiles KA; Dong KK; Canning MT; Grimson R; Walfield AM; Yarosh DB J Cosmet Dermatol; 2007 Jun; 6(2):83-8. PubMed ID: 17524123 [TBL] [Abstract][Full Text] [Related]
31. Community-based trial of a triple-combination agent for the treatment of facial melasma. Grimes P; Kelly AP; Torok H; Willis I Cutis; 2006 Mar; 77(3):177-84. PubMed ID: 16610738 [TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos. Mendoza CG; Singzon IA; Handog EB Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986 [TBL] [Abstract][Full Text] [Related]
33. In Vitro and In Vivo Efficacy and Tolerability of a Non-Hydroquinone, Multi-Action Skin Tone Correcting Cream. Grimes PE; McDaniel DH; Wortzman M; Nelson D J Drugs Dermatol; 2019 Jul; 18(7):642-648. PubMed ID: 31329402 [TBL] [Abstract][Full Text] [Related]
34. Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study. Woodhall KE; Goldman MP; Gold MH; Biron J J Drugs Dermatol; 2009 Sep; 8(9):862-7. PubMed ID: 19746679 [TBL] [Abstract][Full Text] [Related]
35. The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies. Fleischer AB; Schwartzel EH; Colby SI; Altman DJ J Am Acad Dermatol; 2000 Mar; 42(3):459-67. PubMed ID: 10688717 [TBL] [Abstract][Full Text] [Related]
36. Hydroquinone-free Skin Brightener System for the Treatment of Moderate-to-severe Facial Hyperpigmentation. Herndon JH; Makino ET; Stephens TJ; Mehta RC J Clin Aesthet Dermatol; 2014 May; 7(5):27-31. PubMed ID: 24847406 [TBL] [Abstract][Full Text] [Related]
37. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma. Grimes PE Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882 [TBL] [Abstract][Full Text] [Related]